P
Physidia
Home hemodialysis
About Physidia
Physidia specializes in providing innovative home dialysis solutions aimed at improving the quality of life for patients with chronic renal failure. The company focuses on daily home hemodialysis, allowing patients to integrate their treatment seamlessly into their daily lives, thus promoting comfort and independence. Physidia serves individuals suffering from renal insufficiency, offering them a choice to manage their condition from the comfort of their homes. Operating in the healthcare market, particularly in the renal care segment, Physidia's business model revolves around the sale and support of its dialysis equipment and services. The company generates revenue through the direct sale of its dialysis machines, ongoing maintenance services, and customer support. By prioritizing patient comfort and freedom, Physidia aims to transform the traditional approach to dialysis treatment.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2010
- Headquarters
- Saint-Barthélemy-d'Anjou, France
- Employees
- 77
- Open positions
- None listed
- Dealroom signal
- 74.2/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Missionfrenchtech, biotech medtech and e-health, Observatoire Deeptech, observatoire industrial tech, DT and LS, observatoire healthtech, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b, b2c
- Investment activity
- 1 company, latest Mar 2026
- Capital deployed
- —
- Preferred round
- ACQUISITION
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| BUYOUT✓Exit | Jun 2023 | $0 | — | Columna Capital | ↗ |
| LATE VC✓Equity / VC | Oct 2016 | $17M | $66M | Bpifrance | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Physidia is 410 monthly website visits, down 51.8% over the last three months. Physidia's team grew 6.9% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later2 investors entered at this stage
Bpifrance
Columna Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Physidia on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Physidia’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.